Home
CiRA Foundation

CiRA Foundation Market Share Analysis for July 2026

iPS財団では、iPS細胞を用いて再生医療の研究開発を推進している研究機関・企業を対象に、受託サービスも提供しております。

Health > Biotechnology and Pharmaceuticals

Domaincira-foundation.or.jp

Year Founded--

Employees51 - 200

Annual Revenue--

CiRA Foundation

CiRA Foundation (including company regionals)

cira-foundation.or.jp

See more website traffic and engagement information

Total visits to CiRA Foundation's top domains

Understand CiRA Foundation market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

cira-foundation.or.jp88.8K

See more with Sales Intelligence

Avg. visit duration in CiRA Foundation's top domains

Analyze CiRA Foundation engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

cira-foundation.or.jp00:01:47

See more with Sales Intelligence

Avg. pageviews on CiRA Foundation's top domains

See how CiRA Foundation keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

cira-foundation.or.jp1.86

See more with Sales Intelligence

CiRA Foundation top competitors by domain

Top similar sites in July 2026, ranked by their affinity

takara-bio.co.jpCompany NameTakara Bio IncEmployees201 - 500HQSweden, GothenburgAnnual revenue$25M - $50MTotal visits126.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by CiRA Foundation

These are the website technologies, by industry, used by CiRA Foundation top domains

Advertising (14)

DoubleClick

Conversion & Analytics (5)

Google Analytics

Social (4)

Instagram

Widget (3)

reCAPTCHA

More Technologies

9

See all

News & Signals from CiRA Foundation

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCiRA Foundation is developing iPS Project.To solve these issues, the CiRA Foundation is working on a project titled "my iPS Project," in which Terumo BCT is participating.

NewsCiRA Foundation is developing methods for establishing iPS cells using liposomes technology.Toshiba Corporation and the CiRA Foundation have begun joint research to develop methods for establishing iPS cells (induced pluripotent stem cells) using liposomes technology.

NewsCiRA Foundation partnered with KOTAI Biotechnologies, Inc. on Oct 1st '20.CiRA and KOTAI have started the joint research in October, 2020 to establish more efficacious personalized cancer immune cell therapies using a surface antigen[4] specifically expressed on anti-cancer cytotoxic T cells and immuno-informatics technologies possessed by KOTAI.